Home » Newsletters » BioWorld Science

BioWorld Science

July 26, 2022

View Archived Issues

THR-beta agonists described by Shanghai Kunheng Pharmaceutical Technology, Kunming Pharmaceutical

Shanghai Institute of Materia Medica identifies new nagilactone derivatives

New SOS-1 inhibitors discovered at Chengdu Baiyu Pharmaceutical

Discovery of allosteric mutant-selective EGFR inhibitor for the treatment of NSCLC

Sarissa presents new DNA repair protein RAD51 homolog 1 inhibitors

New CDC7 inhibitors synthesized at Medshine Discovery

FDA accepts IND for HOOKIPA's arenaviral immunotherapy HB-300 for metastatic CRPC

Altamira Therapeutics to develop OligoPhore-based AM-411 for rheumatoid arthritis

PsychoGenics to evaluate preclinical antiseizure efficacy of IAMA's selective NKCC1 inhibitors

Oryzon collaborates with CMTRF to evaluate HDAC6 inhibitors for Charcot-Marie-Tooth disease

RNF31 as a novel therapeutic target for immunotherapy-refractory cancers

New compound advances anoctamin-1 inhibition for analgesia

Nonessential but critical, tyrosine plays key role in nutrient sensing

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...